Corporate ActionAug 4, 2026, 06:07 AM
Alterity Therapeutics Files Application for Securities Quotation
AI Summary
Alterity Therapeutics Limited has filed a Form 6-K with the U.S. Securities and Exchange Commission. The report includes Exhibit 99.1, which is an application for the quotation of the company's securities, identified as ATH. This filing is a standard corporate action related to the company's securities.
Key Highlights
- Alterity Therapeutics filed a Form 6-K with the SEC.
- The filing includes Exhibit 99.1, an application for quotation of securities (ATH).
Price Impact
More from ATHE